gdc
PSS Guide 2023
Colorectal CancerFinancial Support

Drugs for Colorectal Cancer

Find financial assistance programs available for colorectal cancer drugs.

Avastin (bevacizumab) Injection

Drug company: Genentech
866-422-2377

Genentech Oncology provides 2 financial assistance programs for patients who are using Avastin:

Genentech Oncology Co‑pay Assistance Program

Genentech Patient Foundation

Braftovi (encorafenib) Capsules

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together offers 2 financial assistance programs for patients who have been prescribed Braftovi:

Co‑pay Assistance Program

Pfizer Patient Assistance Program

Camptosar (irinotecan hydrochloride) Injection

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together provides 1 financial assistance program for patients using Camptosar:

Pfizer Patient Assistance Program

Cyramza (ramucirumab) Injection

Drug company: Eli Lilly
866-472-8663

Lilly Oncology provides 2 financial assistance programs for patients using Cyramza:

Lilly Oncology Infused Products Co‑pay Program

Lilly Cares Foundation Patient Assistance Program

Erbitux (cetuximab)

Drug company: Eli Lilly
866-472-8663

Lilly Oncology provides 2 financial assistance programs for patients using Erbitux:

Lilly Oncology Infused Products Co‑pay Program

Lilly Cares Foundation Patient Assistance Program

Keytruda (pembrolizumab)

Drug company: Merck
855-257-3932

Merck offers 2 financial assistance programs for patients who have been prescribed Keytruda:

Merck Co‑pay Assistance Program

Merck Patient Assistance Program

Lonsurf (trifluridine + tipiracil) Tablets

Drug company: Taiho Oncology
844-824-4648

Taiho Oncology Patient Support provides 2 financial assistance programs for patients using Lonsurf:

Taiho Oncology Patient Support Co‑pay Card

Taiho Oncology Patient Support Program

Mvasi (bevacizumab-awwb)

Drug company: Amgen
888-427-7478

Amgen Assist 360 offers 2 financial assistance programs for patients who have been prescribed Mvasi:

Amgen FIRST STEP Co‑Pay Program

Amgen Safety Net Foundation

Opdivo (nivolumab)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Opdivo:

BMS Oncology Co‑pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Stivarga (regorafenib) Tablets

Drug company: Bayer
866-639-2827

Bayer provides 2 financial assistance programs for patients using Stivarga:

STIVARGA $0 Co‑pay Program

Bayer US Patient Assistance Foundation

Vectibix (panitumumab)

Drug company: Amgen
888-427-7478

Amgen Assist 360 provides 2 financial assistance programs for patients using Vectibix:

Amgen FIRST STEP Co‑pay Program

Amgen Safety Net Foundation

Xeloda (capecitabine) Tablets

Drug company: Genentech
866-422-2377

Genentech Oncology provides 1 financial support program for patients who are prescribed Xeloda:

Genentech Patient Foundation

Yervoy (ipilimumab)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Yervoy:

BMS Oncology Co‑pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Zirabev (bevacizumab-bvzr)

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together offers 2 financial assistance programs for patients who have been prescribed Zirabev:

Pfizer Oncology Together Co‑pay Savings Program

Pfizer Patient Assistance Program

Table. Drugs Prescribed for Colorectal Cancer

  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
    Drug name (generic name)
  • Avastin (bevacizumab) Injection
  • Drug company
  • Genentech
  • Indication
  • First-line or second-line therapy for metastatic colorectal cancer, in combination with IV-based chemotherapy

    Second-line treatment, in combination with a chemotherapy regimen, for metastatic colorectal cancer that progressed with a first-line Avastin-containing regimen
  • Patient support services
  • Genentech Oncology Co‑pay Assistance Program
    855-692-6729

    Genentech Patient Foundation
    888-941-3331

    Drug name (generic name)
  • Braftovi (encorafenib) Capsules
  • Drug company
  • Pfizer
  • Indications
  • Treatment of adults with metastatic colorectal cancer and BRAF V600E mutation, as detected by an FDA-approved test
  • Patient support services
  • Co‑pay Assistance Program
    877-744-5675

    Pfizer Patient Assistance Program
    877-744-5675

    Drug name (generic name)
  • Camptosar (irinotecan hydrochloride) Injection
  • Drug company
  • Pfizer
  • Indications
  • First-line therapy for metastatic carcinoma of the colon or rectum, in combination with 5-fluorouracil and leucovorin

    Second-line therapy for metastatic carcinoma of the colon or rectum, after chemotherapy
  • Patient support services
  • Pfizer Patient Assistance Program
    877-744-5675


    Drug name (generic name)
  • Erbitux (cetuximab)
  • Drug company
  • Eli Lilly
  • Indication
  • First-line treatment of patients with EGFR-expressing, but without KRAS mutation, metastatic colorectal cancer, in combination with a chemotherapy regimen, after previous therapy

    Treatment, in combination with irinotecan chemotherapy, of colorectal cancer that progressed after irinotecan, or alone in patients who cannot tolerate irinotecan

    Treatment, in combination with Braftovi, of adults with metastatic colorectal cancer and BRAF V600E mutation, as detected by an FDAapproved test
  • Patient support services
  • Lilly Oncology Infused Products Co‑pay Program
    866-472-8663

    Lilly Cares Foundation Patient Assistance Program
    800-545-6962



    Drug name (generic name)
  • Mvasi (bevacizumab-awwb)
  • Drug company
  • Amgen
  • Indication
  • Treatment of metastatic colorectal cancer, in combination with chemotherapy, or after disease progression with a bevacizumab-containing regimen
  • Patient support services
  • Amgen FIRST STEP Co‑pay Program
    866-264-2778

    Amgen Safety Net Foundation
    866-264-2778



    Drug name (generic name)
  • Vectibix (panitumumab)
  • Drug company
  • Amgen
  • Indication
  • First-line therapy of metastatic colorectal cancer, in combination with chemotherapy

    Metastatic colorectal cancer, after chemotherapy
  • Patient support services
  • Amgen FIRST STEP Co‑pay Program
    866-264-2778

    Amgen Safety Net Foundation
    866-264-2778

    Drug name (generic name)
  • Xeloda (capecitabine) Tablets
  • Drug company
  • Genentech
  • Indication
  • Adjuvant therapy for colon cancer, specifically Dukes’ C colon cancer

    First-line therapy for metastatic colorectal cancer
  • Patient support services
  • Genentech Patient Foundation
    888-941-3331


    Drug name (generic name)
  • Zirabev (bevacizumabbvzr)
  • Drug company
  • Pfizer
  • Indication
  • First- or second-line treatment, in combination with fluorouracil-based chemotherapy, of metastatic colorectal cancer

    Second-line treatment, in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy, of metastatic colorectal cancer in patients whose disease progressed during a first-line regimen containing a bevacizumab drug
  • Patient support services
  • Pfizer Oncology Together Co‑pay Savings Program
    877-744-5675

    Pfizer Patient Assistance Program
    877-744-5675

dMMR indicates mismatch repair-deficient; MSI-H, microsatellite instability-high.
Last modified: March 9, 2023

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link

Subscribe to Conquer: the journey informed

Receive timely cancer news & updates, patient stories, and more.


Country
Race or Ethnicity
Gender
Profession or Role
Primary Interest
Other Interests